Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
16,915
Total Value
$222,589.49
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 29, 2026 | Sale | 8,458 | $13.09 | $110,736.36 | 8,880 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 30, 2026 | Sale | 8,457 | $13.23 | $111,853.13 | 423 | Direct | โ | View Details |